Cambridge Nutritional Sciences (CNSL) Competitors GBX 3.38 -0.07 (-1.88%) As of 11:49 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarnings CNSL vs. CEL, FOX, OTT, BCE, CZN, CHT, DVW, BRCI, NPT, and RCIShould you be buying Cambridge Nutritional Sciences stock or one of its competitors? The main competitors of Cambridge Nutritional Sciences include Celadon Pharmaceuticals (CEL), Fox Marble (FOX), Oxford Technology 3 Venture Capital Trust (OTT), Beacon Energy (BCE), Curzon Energy (CZN), 290005 (CHT.L) (CHT), 5008 (DVW.L) (DVW), BlackRock Comms Income Inv Tst (BRCI), NetPlay TV (NPT), and RapidCloud International (RCI). These companies are all part of the "communication" industry. Cambridge Nutritional Sciences vs. Celadon Pharmaceuticals Fox Marble Oxford Technology 3 Venture Capital Trust Beacon Energy Curzon Energy 290005 (CHT.L) 5008 (DVW.L) BlackRock Comms Income Inv Tst NetPlay TV RapidCloud International Celadon Pharmaceuticals (LON:CEL) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, community ranking, dividends, media sentiment, institutional ownership and valuation. Which has more risk and volatility, CEL or CNSL? Celadon Pharmaceuticals has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500. Comparatively, Cambridge Nutritional Sciences has a beta of 3.89, suggesting that its stock price is 289% more volatile than the S&P 500. Do institutionals and insiders hold more shares of CEL or CNSL? 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. Comparatively, 10.2% of Cambridge Nutritional Sciences shares are held by institutional investors. 65.1% of Celadon Pharmaceuticals shares are held by company insiders. Comparatively, 10.9% of Cambridge Nutritional Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer CEL or CNSL? In the previous week, Celadon Pharmaceuticals' average media sentiment score of 0.05 beat Cambridge Nutritional Sciences' score of 0.00 indicating that Celadon Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Celadon Pharmaceuticals Neutral Cambridge Nutritional Sciences Neutral Is CEL or CNSL more profitable? Celadon Pharmaceuticals has a net margin of 0.00% compared to Cambridge Nutritional Sciences' net margin of -3.36%. Cambridge Nutritional Sciences' return on equity of -3.34% beat Celadon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Celadon PharmaceuticalsN/A -190.71% -34.40% Cambridge Nutritional Sciences -3.36%-3.34%-2.36% Which has preferable earnings and valuation, CEL or CNSL? Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeladon Pharmaceuticals£11.26K1,107.54-£5.23M-£0.08-226.38Cambridge Nutritional Sciences£9.77M0.78-£3.03MN/AN/A Does the MarketBeat Community believe in CEL or CNSL? Celadon Pharmaceuticals received 4 more outperform votes than Cambridge Nutritional Sciences when rated by MarketBeat users. CompanyUnderperformOutperformCeladon PharmaceuticalsOutperform Votes4100.00% Underperform VotesNo VotesCambridge Nutritional SciencesN/AN/A SummaryCeladon Pharmaceuticals beats Cambridge Nutritional Sciences on 7 of the 12 factors compared between the two stocks. Get Cambridge Nutritional Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNSL vs. The Competition Export to ExcelMetricCambridge Nutritional SciencesMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£7.61M£3.29B£5.51B£2.06BDividend YieldN/A2.01%5.36%5.15%P/E Ratio-362.10337.8074.081,935.24Price / Sales0.78157.441,216.82360,137.87Price / CashN/A146.5444.3029.30Price / Book0.803.025.043.09Net Income-£3.03M£91.96M£117.51M£185.74M7 Day Performance-11.11%2.95%0.81%0.16%1 Month Performance16.83%5.91%3.85%2.80%1 Year Performance28.51%-1.32%25.73%156.49% Cambridge Nutritional Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNSLCambridge Nutritional SciencesN/AGBX 3.39-1.9%N/AN/A£8.06M£9.77M-362.103,200Insider TradeGap DownCELCeladon PharmaceuticalsN/AGBX 20.40+4.6%N/A-76.0%£14.05M£11,258.00-255.002,780News CoverageGap DownFOXFox MarbleN/AN/AN/AN/A£5.63M£722,064.00-135.0010,600OTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M£-85,000.00-12.59203Gap DownBCEBeacon EnergyN/AGBX 0.01+25.0%N/A-93.3%£926,000.00N/A-0.3544,600Gap UpCZNCurzon EnergyN/AN/AN/AN/A£34,000.00N/A-3.4014,700Gap DownCHT290005 (CHT.L)N/AN/AN/AN/A£0.00N/A0.0020,300DVW5008 (DVW.L)N/AN/AN/AN/A£0.00N/A0.00N/AGap UpBRCIBlackRock Comms Income Inv TstN/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading VolumeNPTNetPlay TVN/AN/AN/AN/A£0.00N/A0.00147,000RCIRapidCloud InternationalN/AN/AN/AN/A£0.00N/A0.0023,000 Related Companies and Tools Related Companies Celadon Pharmaceuticals Competitors Fox Marble Competitors Oxford Technology 3 Venture Capital Trust Competitors Beacon Energy Competitors Curzon Energy Competitors 290005 (CHT.L) Competitors 5008 (DVW.L) Competitors BlackRock Comms Income Inv Tst Competitors NetPlay TV Competitors RapidCloud International Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CNSL) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
